ChemoCentryx Inc (CCXI)
NASDAQ
14.09
-0.48 (-3.29%)
Closed
Aug 24, 2026
Day's Range
13.8114.33
52 wk Range
10.0719.69
Financial Statements - CCXI - ChemoCentryx Inc
Revenue
31.90M▼ 50.5%
Net Income
-131.75M▼ 138.0%Net Margin -413.0%
EBITDA
-125.92M▼ 142.5%
Free Cash Flow
-94.64M▲ 2.0%
Income Statement
| Period Ending | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|
| Sales | 31.90M | 64.39M | 35.95M | 42.87M |
| Cost of Goods | 302K | - | - | - |
| Gross Profit | 31.59M | - | - | - |
 Operating Expense | - | - | - | - |
| Operating Income | -129.91M | -55.17M | -58.30M | -40.27M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | -1.83M | -179K | 2.81M | 2.30M |
| Pre Tax Income | -131.75M | -55.35M | -55.48M | -37.96M |
| Income Tax | - | - | - | - |
| Net Income | -131.75M | -55.35M | -55.48M | -37.96M |
| EPS Basic | -1.89 | -0.84 | -0.98 | -0.76 |
| EPS Diluted | -1.89 | -0.84 | -0.98 | -0.76 |
| Basic Shares Outstanding | 69.85M | 65.68M | 56.89M | 49.81M |
| Diluted Shares Outstanding | 69.85M | 65.68M | 56.89M | 49.81M |
| Ebit | - | - | - | - |
| Ebitda | -125.92M | -51.91M | -51.69M | -36.23M |
| Net Income Continuous Operations | -131.75M | -55.35M | -55.48M | -37.96M |
| Minority Interests | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
